Skip to content

Effect of Early use of in-line speaking valve on time to wean from mechanical ventilation in Intensive Care Unit patients with tracheostomies: a pilot randomised controlled trial

Effect of Early use of in-line speaking valve on time to wean from mechanical ventilation in Intensive Care Unit patients with tracheostomies: a pilot randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624000952549
Enrollment
2
Registered
2024-08-06
Start date
2024-04-04
Completion date
2026-12-25
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

In patients who are unable to be safely taken off a mechanical ventilator a tracheostomy is often placed to help protect their airway gradually reduce the mechanical ventilator support. One-way valves can be used within a ventilator circuit to direct air through the upper airway during expiration, allowing speech and communication.  Research suggests the use of speaking valves during mechanical ventilation is safe, improves communication, may reduce time to weaning off ventilation and removal of tracheostomy. This project aims to evaluate whether the early use of a speaking valve within the ventilator circuit in suitable patients results in earlier weaning from mechanical ventilation and earlier communication.   The primary outcome will be feasibility and safety with the ability to pivot to a primary outcome of duration of mechanical ventilation post tracheostomy utilising the pilot results.  Secondary outcomes include mechanical ventilation duration, ease of communication, patient and family, satisfaction and length of stay.

Interventions

Early use of speaking valve in patients who have received tracheostomy in intensive care units (within 72 hours of tracheostomy insertion) 1.Insertion of standard one way speaking valve into ventilator circuit (speaking valve is put into ventilator circuit for the period of the intervention) 2. Initial application will be performed by speech pathologist and physiotherapist and within 72 hours of tracheostomy. Subsequent applications may be done by suitably trained nursing staff 3. Aim will be f

Early use of speaking valve in patients who have received tracheostomy in intensive care units (within 72 hours of tracheostomy insertion) 1.Insertion of standard one way speaking valve into ventilator circuit (speaking valve is put into ventilator circuit for the period of the intervention) 2. Initial application will be performed by speech pathologist and physiotherapist and within 72 hours of tracheostomy. Subsequent applications may be done by suitably trained nursing staff 3. Aim will be for 30-60 minutes initially once and then twice daily up to 60 minutes the following day (may be extended longer with time recorded if tolerated well by the patient). The speaking valve is removed from ventilator circuit at the end of each trial. This will continue daily until the patient is weaned from the ventilator (at which point all patients will have access to non ventilator circuit speaking valves as is standard practice) 4. Successful application, time applied/duration will be recorded and any reason for failure Ventilator strategies will be as per the treating clinician

Sponsors

Sir Charles Gairdner Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Tracheostomy inserted in ICU – air filled cuffed tube Mechanically ventilated but able to spontaneously breathe Able to obey one stage commands within the previous 24 hrs Tracheostomy leak demonstrated on cuff deflation to be >40% of tidal volumes >18 years of age Within 72 hrs of tracheostomy Expected stay in ICU beyond next calendar day

Exclusion criteria

Deemed unsuitable for speaking valve by primary physician – reason to be recorded Requiring heavy sedation for high intracranial pressures PEEP required >10 FiO2 required >60% Severe airway obstruction which may prevent sufficient exhalation Severely reduced lung elasticity which may cause air trapping

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026